Cargando…
3D models in the new era of immune oncology: focus on T cells, CAF and ECM
Immune checkpoint inhibitor therapy has changed clinical practice for patients with different cancers, since these agents have demonstrated a significant improvement of overall survival and are effective in many patients. However, an intrinsic or acquired resistance frequently occur and biomarkers p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429763/ https://www.ncbi.nlm.nih.gov/pubmed/30898166 http://dx.doi.org/10.1186/s13046-019-1086-2 |